egtazic acid has been researched along with Disease Models, Animal in 52 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (7.69) | 18.7374 |
| 1990's | 7 (13.46) | 18.2507 |
| 2000's | 18 (34.62) | 29.6817 |
| 2010's | 20 (38.46) | 24.3611 |
| 2020's | 3 (5.77) | 2.80 |
| Authors | Studies |
|---|---|
| Braisted, J; Dranchak, P; Earnest, TW; Gu, X; Hoon, MA; Inglese, J; Oliphant, E; Solinski, HJ | 1 |
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Chen, H; Li, Z; Lin, F; Ling, M; Ma, R; Pan, L; Ye, L; Zeng, Q | 1 |
| Bulte, JWM; Chu, C; Song, X; Walczak, P; Wei, Z; Yuan, Y; Zhang, J | 1 |
| Ham, S; Han, JS; Han, S; Jung, YK; Kim, J; Lee, KW; Lee, S; Park, JHY; Shim, I | 1 |
| Arnoux, I; Barger, Z; Bittner, S; Ellwardt, E; Jubal, ER; Kuhlmann, T; Luchtman, D; Lutz, B; Mandal, S; Mittmann, T; Novkovic, T; Pramanik, G; Ruiz de Azua, I; Schmalz, M; Stroh, A; Vogelaar, CF; Vogt, J; Zipp, F | 1 |
| Cameron, SJ; Cooley, BC; Jobe, SM; Kholmukhamedov, A; Morrell, CN; Schulte, ML; Scoggins, NO; Silverstein, RL; Wood, JP; Yang, M | 1 |
| Chai, Z; Dong, QP; He, JQ | 1 |
| Centonze, D; Fresegna, D; Gentile, A; Haji, N; Mandolesi, G; Matarese, G; Motta, C; Musella, A; Paolillo, A; Rossi, S; Sepman, H; Studer, V | 1 |
| Gao, RS; Liu, FF; Lu, L; Pu, L; Xu, XS; Zhang, SZ; Zhang, YW; Zheng, QQ | 1 |
| Chang, CY; Chou, SS; Huang, SK; Lin, TY; Lu, CW; Wang, SJ; Wang, YC | 1 |
| He, K; Pei, H; Su, L; Wang, Q; Wei, S; Yang, D; Yang, Y; Zhang, Y | 1 |
| Chen, J; Chen, L; Cheng, R; Ma, Q; Pan, X; Wang, G; Wang, L; Wang, W; Wu, H; Zhang, J; Zhang, M | 1 |
| Casini, S; de Bakker, JM; Tan, HL; van Borren, MM; van Ginneken, AC; Veldkamp, MW; Verkerk, AO | 1 |
| Bahinski, A; Cazorla, O; Flagg, TP; Haim, TE; Kovacs, A; Nerbonne, JM; Nichols, CG; Numann, RE; Remedi, MS; Schaffer, JE; Tones, MA | 1 |
| Bao, Y; Matsumoto, AH; Miyoshi, T; Sheehan, JP; Shi, W; Yuan, Z | 1 |
| Bähr, M; Boretius, S; Diem, R; Fairless, R; Frahm, J; Gadjanski, I; Hochmeister, S; Knöferle, J; Lingor, P; Michaelis, T; Sättler, MB; Storch, MK; Sühs, KW; Williams, SK | 1 |
| Bonanno, G; Bonifacino, T; Cervetto, C; Jacchetti, E; Milanese, M; Usai, C; Zappettini, S | 1 |
| Araki, E; Fukuda, K; Ishii, N; Kawada, T; Kim-Mitsuyama, S; Kinoshita, H; Matsumura, T; Miyamura, N; Motoshima, H; Nakao, S; Nishikawa, T; Senokuchi, T; Takeya, M; Tsutsumi, A | 1 |
| Borda, E; Busch, L; Miozza, V; S-Borda, L | 1 |
| Clausen, T; Hofman-Bang, J; Lewin, E; Martuseviciene, G; Olgaard, K | 1 |
| Hsieh, YC; Lin, JC; Lin, SF; Lin, TC; Ting, CT; Wu, TJ | 1 |
| Li, Y; Ma, C; Ma, J; Ríos, E; Weisleder, N; Yi, J; Zhou, J | 1 |
| Barrett, EF; Barrett, JN; David, G; Talbot, JD | 1 |
| Arba, F; Balami, JS; Buchan, AM; Kleinschnitz, C; Minnerup, J; Sutherland, BA | 1 |
| Choi, SH; Hwang, SH; Jang, CG; Kang, J; Kim, HC; Kim, HJ; Kwon, SH; Lee, BH; Lee, JH; Nah, SY; Shin, EJ; Shin, TJ | 1 |
| Agarwal, S; Chitnis, CE; Garg, S; Singh, MK; Singh, S | 1 |
| He, Z; Hoopfer, E; Kim, A; Liu, Q; Luo, L; Mitchison, T; Wang, J; Watts, R; Zhai, Q | 1 |
| Matsuka, Y; Spigelman, I | 1 |
| Bednarski, JJ; Boitano, AE; Glick, GD; Lyssiotis, CA; Opipari, AW; Roush, R | 1 |
| Bartnik, BL; Obenaus, A; Spigelman, I | 1 |
| Rinaldi, GJ | 1 |
| Ayala, GX; Tapia, R | 1 |
| Alpini, G; Benedetti, A; Fava, G; Francis, H; Glaser, S; Mancino, MG; Marzioni, M; Reichenbach, R; Summers, R; Ueno, Y; Venter, J | 1 |
| Haas, J; Menon, K; Sahu, SK; Wu, Y; Yang, B; Zaheer, A | 1 |
| Alsaied, OA; Baranova, O; Beal, MF; Calingasan, NY; Chavez, JC; Friedman, JE; Kiaei, M; Petri, S; Wille, E | 1 |
| Auberson, YP; Carmignoto, G; Coulter, DA; Ding, S; Fellin, T; Haydon, PG; Lee, SY; Meaney, DF; Zhu, Y | 1 |
| Cho, HJ; Huh, K; Jin, SM; Mook-Jung, I; Youn, HD | 1 |
| Caragounis, A; Crouch, PJ; Du, T; Filiz, G; Price, KA; White, AR | 1 |
| Halloran, B; Hulter, HN; Ilnicki, LP; Sebastian, A; Toto, RD | 1 |
| Schmidt, WK; Way, EL | 1 |
| Ackerman, JJ; Hotchkiss, RS; Karl, IE; Song, SK | 1 |
| Foley, PL; Kassell, NF; Lee, KS; Takenaka, K | 1 |
| Anderson, HC; Hsu, HH | 1 |
| Bryant, SM; Hart, G; Shipsey, SJ | 1 |
| Beck, H; Elger, CE; Goussakov, IV; Kunz, WS | 1 |
| Lewin, E; Olgaard, K; Wang, W | 1 |
| Sanabria, ER; Su, H; Yaari, Y | 1 |
| Horton, JW; Tang, H; Xia, Z; Yang, Y | 1 |
| Kawai, N; Kirino, T; Miwa, A; Robinson, HP; Tamura, A | 1 |
| Freeman, GB; Gibson, GE; Mykytyn, V | 1 |
| Ehrlich, MG | 1 |
2 review(s) available for egtazic acid and Disease Models, Animal
| Article | Year |
|---|---|
Neuroprotection for ischaemic stroke: translation from the bench to the bedside.
Topics: Acute Disease; Animals; Benzenesulfonates; Brain Ischemia; Chelating Agents; Clinical Trials as Topic; Combined Modality Therapy; Diffusion of Innovation; Disease Models, Animal; Drug Evaluation, Preclinical; Egtazic Acid; Hematopoietic Cell Growth Factors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypothermia, Induced; Magnesium; Minocycline; NADPH Oxidases; Neuroprotective Agents; Pregnatrienes; Serum Albumin; Stroke; Thrombolytic Therapy; Translational Research, Biomedical | 2012 |
The role of metals in modulating metalloprotease activity in the AD brain.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Brain; Cell Culture Techniques; Chelating Agents; Clioquinol; Copper; Disease Models, Animal; Egtazic Acid; Enzyme Activation; ErbB Receptors; Humans; Intracellular Space; Matrix Metalloproteinases, Secreted; Mitogen-Activated Protein Kinases; Plaque, Amyloid; Proline; Thiocarbamates; Trace Elements; Zinc | 2008 |
50 other study(ies) available for egtazic acid and Disease Models, Animal
| Article | Year |
|---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, Spinal; Humans; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pruritus; Receptors, Atrial Natriuretic Factor; Reproducibility of Results; Signal Transduction; Small Molecule Libraries | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Inhibition of IP3R/Ca2+ Dysregulation Protects Mice From Ventilator-Induced Lung Injury
Topics: Animals; Apoptosis; Boron Compounds; Calcium; Calcium Chelating Agents; Calcium Signaling; Carbachol; Disease Models, Animal; Egtazic Acid; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Inflammasomes; Inflammation Mediators; Inositol 1,4,5-Trisphosphate Receptors; Lung; Macrophages; Male; Mice; Mice, Inbred C57BL; Mitochondria; NLR Family, Pyrin Domain-Containing 3 Protein; RAW 264.7 Cells; Ventilator-Induced Lung Injury | 2021 |
Development of Zinc-Specific iCEST MRI as an Imaging Biomarker for Prostate Cancer.
Topics: Animals; Biomarkers, Tumor; Cell Line, Tumor; Contrast Media; Disease Models, Animal; Egtazic Acid; Fluorine; Humans; Magnetic Resonance Imaging; Male; Mice; Mice, Transgenic; Prostatic Neoplasms; Zinc | 2019 |
Ca2+-permeable TRPV1 pain receptor knockout rescues memory deficits and reduces amyloid-β and tau in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Calcium; Calcium Channels; Capsaicin; Chelating Agents; Disease Models, Animal; Egtazic Acid; Hippocampus; Learning; Memory Disorders; Mice; Mice, Knockout; Nociceptors; tau Proteins; TRPV Cation Channels | 2020 |
Maladaptive cortical hyperactivity upon recovery from experimental autoimmune encephalomyelitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Cells, Cultured; Cerebral Cortex; Cuprizone; Disease Models, Animal; Egtazic Acid; Encephalomyelitis, Autoimmune, Experimental; Excitatory Amino Acid Antagonists; Female; Freund's Adjuvant; Hyperkinesis; Membrane Potentials; Mice; Mice, Transgenic; Microglia; Myelin Proteolipid Protein; Peptide Fragments; Proto-Oncogene Proteins c-fos; Quinoxalines; Recovery of Function; Sodium Channel Blockers; Tetrodotoxin | 2018 |
Platelet CD36 signaling through ERK5 promotes caspase-dependent procoagulant activity and fibrin deposition in vivo.
Topics: Animals; Blood Platelets; Caspases; CD36 Antigens; Crotalid Venoms; Diet, High-Fat; Disease Models, Animal; Egtazic Acid; Fibrin; Humans; Hyperlipidemias; Lectins, C-Type; Lipoproteins, LDL; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 7; Phosphatidylserines; Platelet Activation; Signal Transduction; src-Family Kinases; Thrombosis | 2018 |
Astrocytic Ca(2+) waves mediate activation of extrasynaptic NMDA receptors in hippocampal neurons to aggravate brain damage during ischemia.
Topics: Animals; Astrocytes; Brain Injuries; Brain Ischemia; Calcium; Calcium Signaling; Chelating Agents; Disease Models, Animal; Egtazic Acid; Excitatory Amino Acid Agents; Female; Glucose; Hippocampus; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Inositol 1,4,5-Trisphosphate Receptors; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurons; Rats; Rats, Sprague-Dawley | 2013 |
Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis.
Topics: Animals; Cell Proliferation; Cerebral Cortex; Chelating Agents; Cladribine; Corpus Striatum; Disease Models, Animal; Drug Delivery Systems; Egtazic Acid; Encephalomyelitis, Autoimmune, Experimental; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Female; Glial Fibrillary Acidic Protein; Glutamic Acid; Immunosuppressive Agents; In Vitro Techniques; Interleukin-1beta; Mice; Mice, Inbred C57BL; Neuroglia; Patch-Clamp Techniques; Synapses | 2013 |
Calcium signaling mediates antifungal activity of triazole drugs in the Aspergilli.
Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Aspergillus nidulans; Calcium Chelating Agents; Calcium Signaling; Culture Media; Disease Models, Animal; Egtazic Acid; Gene Expression Profiling; Invasive Pulmonary Aspergillosis; Itraconazole; Lepidoptera; Real-Time Polymerase Chain Reaction; Treatment Outcome; Triazoles | 2015 |
Hesperidin inhibits glutamate release and exerts neuroprotection against excitotoxicity induced by kainic acid in the hippocampus of rats.
Topics: 4-Aminopyridine; Animals; Calcium; Disease Models, Animal; Egtazic Acid; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Glutamic Acid; Hesperidin; Hippocampus; Kainic Acid; Male; Membrane Potentials; Neuroprotective Agents; Neurotoxicity Syndromes; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Sodium Channel Blockers; Synaptosomes; Tetrodotoxin | 2015 |
Activation of transient receptor potential vanilloid 1 accelerates re-endothelialization and inhibits neointimal formation after vascular injury.
Topics: Adenosine Triphosphate; Animals; Calcium Chelating Agents; Capsaicin; Carotid Artery Injuries; Cell Movement; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Egtazic Acid; Endothelial Cells; GTP Phosphohydrolases; Human Umbilical Vein Endothelial Cells; Humans; Hyperplasia; Male; Membrane Potential, Mitochondrial; Mice, Inbred C57BL; Mice, Knockout; Mitochondrial Proteins; Neointima; Re-Epithelialization; RNA Interference; Signal Transduction; Transfection; TRPV Cation Channels | 2017 |
Resveratrol-induced antinociception is involved in calcium channels and calcium/caffeine-sensitive pools.
Topics: Analgesics; Animals; Behavior, Animal; Brain-Derived Neurotrophic Factor; Caffeine; Calcium Channel Blockers; Calcium Channels; Calcium Chelating Agents; Calcium Chloride; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Egtazic Acid; Male; Mice, Inbred ICR; Nociception; Nociceptive Pain; Phosphorylation; Reaction Time; Resveratrol; Ryanodine; Spinal Cord; Stilbenes; Time Factors | 2017 |
Intracellular calcium modulation of voltage-gated sodium channels in ventricular myocytes.
Topics: Action Potentials; Animals; Buffers; Caffeine; Calcium; Cell Line; Cells, Cultured; Disease Models, Animal; Egtazic Acid; Heart Failure; Heart Rate; Heart Ventricles; Homeostasis; Humans; Muscle Proteins; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Patch-Clamp Techniques; Phosphodiesterase Inhibitors; Rabbits; Sodium Channels; Transfection | 2009 |
Ca2+-independent alterations in diastolic sarcomere length and relaxation kinetics in a mouse model of lipotoxic diabetic cardiomyopathy.
Topics: Animals; Calcium; Chelating Agents; Diabetes Complications; Diacetyl; Diastole; Disease Models, Animal; Egtazic Acid; Fatty Acid Transport Proteins; Fatty Acids; Heart Failure, Diastolic; Heart Ventricles; Isometric Contraction; Mice; Mice, Transgenic; Myocardial Contraction; Myocardium; Myocytes, Cardiac; Myosin Heavy Chains; Recombinant Fusion Proteins; Sarcomeres | 2009 |
Microarray analysis of gene expression in mouse aorta reveals role of the calcium signaling pathway in control of atherosclerosis susceptibility.
Topics: Animals; Aorta, Thoracic; Apolipoproteins E; Atherosclerosis; Calcium Signaling; Cells, Cultured; Chelating Agents; Chemokine CCL2; Dietary Fats; Disease Models, Animal; Egtazic Acid; Endothelial Cells; Female; Gene Expression Profiling; Genetic Predisposition to Disease; Lipoproteins, LDL; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Knockout; Oligonucleotide Array Sequence Analysis; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; RNA; Species Specificity | 2009 |
Role of n-type voltage-dependent calcium channels in autoimmune optic neuritis.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Amlodipine; Amyloid beta-Protein Precursor; Animals; Autoimmune Diseases; Calcium; Calcium Channel Blockers; Calcium Channels, N-Type; Cytokines; Disease Models, Animal; Drug Interactions; Ectodysplasins; Egtazic Acid; Excitatory Amino Acid Antagonists; Female; Glial Fibrillary Acidic Protein; Magnetic Resonance Imaging; Manganese; Myelin Proteins; Myelin-Associated Glycoprotein; Myelin-Oligodendrocyte Glycoprotein; Neoplasm Proteins; omega-Conotoxin GVIA; Optic Nerve; Optic Neuritis; Quinoxalines; Rats; RNA-Binding Proteins | 2009 |
In vitro activation of GAT1 transporters expressed in spinal cord gliosomes stimulates glutamate release that is abnormally elevated in the SOD1/G93A(+) mouse model of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Calcium; Chelating Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Egtazic Acid; GABA Agents; GABA Plasma Membrane Transport Proteins; gamma-Aminobutyric Acid; Gene Expression Regulation; Gliosis; Glutamic Acid; Humans; L-Lactate Dehydrogenase; Mice; Mice, Transgenic; Nerve Tissue Proteins; Nipecotic Acids; Spinal Cord; Superoxide Dismutase | 2010 |
Nifedipine induces peroxisome proliferator-activated receptor-gamma activation in macrophages and suppresses the progression of atherosclerosis in apolipoprotein E-deficient mice.
Topics: Amlodipine; Animals; Apolipoproteins E; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Calcium Channel Blockers; Cardiovascular Agents; Cells, Cultured; Chelating Agents; Chemokine CCL2; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Activation; Flavonoids; Humans; Lipopolysaccharides; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C3H; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mutation; Nifedipine; Phosphorylation; PPAR gamma; Protein Kinase Inhibitors; RNA Interference; RNA, Messenger; Time Factors; Transfection | 2010 |
Increase nitric oxide synthase activity in parotid glands from rats with experimental periodontitis.
Topics: Adenine; Amylases; Animals; Calcium; Cyclic AMP-Dependent Protein Kinase Catalytic Subunits; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Egtazic Acid; Enzyme Inhibitors; Guanidines; Indazoles; Indomethacin; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Organ Size; Ornithine; Parotid Gland; Periodontitis; Piperazines; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Salivary Proteins and Peptides; Thiazoles | 2010 |
The secretory response of parathyroid hormone to acute hypocalcemia in vivo is independent of parathyroid glandular sodium/potassium-ATPase activity.
Topics: Animals; Calcium; Disease Models, Animal; Egtazic Acid; Enzyme Inhibitors; Hypocalcemia; Male; Ouabain; Parathyroid Glands; Parathyroid Hormone; Potassium; Rats; Rubidium Radioisotopes; Sodium-Potassium-Exchanging ATPase; Time Factors | 2011 |
Pretreatment of BAPTA-AM suppresses the genesis of repetitive endocardial focal discharges and pacing-induced ventricular arrhythmia during global ischemia.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Calcium Signaling; Cardiac Pacing, Artificial; Chelating Agents; Disease Models, Animal; Egtazic Acid; Electrocardiography; Endocardium; Fourier Analysis; Myocardial Ischemia; Perfusion; Rabbits; Time Factors; Ventricular Fibrillation; Voltage-Sensitive Dye Imaging | 2011 |
Mitochondrial calcium uptake regulates rapid calcium transients in skeletal muscle during excitation-contraction (E-C) coupling.
Topics: Amyotrophic Lateral Sclerosis; Animals; Calcium; Chelating Agents; Cytosol; Disease Models, Animal; Egtazic Acid; Excitation Contraction Coupling; Membrane Potentials; Mice; Mice, Mutant Strains; Mitochondria, Muscle; Muscle Fibers, Skeletal; Sarcoplasmic Reticulum | 2011 |
Calcium dependence of damage to mouse motor nerve terminals following oxygen/glucose deprivation.
Topics: Animals; Bacterial Proteins; Bungarotoxins; Calcium; Disease Models, Animal; Egtazic Acid; Enzyme Inhibitors; Glucose; Humans; Hypoxia; In Vitro Techniques; Luminescent Proteins; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Endplate; Motor Neuron Disease; Motor Neurons; Neuromuscular Junction; Protein Binding; Superoxide Dismutase; Thiourea; Time Factors | 2012 |
Gintonin, a ginseng-derived lysophosphatidic acid receptor ligand, attenuates Alzheimer's disease-related neuropathies: involvement of non-amyloidogenic processing.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Brain; Calcium; Calcium-Binding Proteins; Cell Survival; Disease Models, Animal; Donepezil; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Inhibitors; Glycoproteins; Humans; Indans; Isoxazoles; Ligands; Maze Learning; Memory Disorders; Metalloproteases; Mice; Mice, Transgenic; Microfilament Proteins; Mutation; Neuroblastoma; Nootropic Agents; Panax; Peptide Fragments; Phytotherapy; Piperidines; Plant Proteins; Presenilin-1; Propionates; Protein Binding; Receptors, Lysophosphatidic Acid; Signal Transduction; Time Factors; Transfection | 2012 |
Ca(2+) -mediated exocytosis of subtilisin-like protease 1: a key step in egress of Plasmodium falciparum merozoites.
Topics: Animals; Calcium; Cells, Cultured; Chelating Agents; Disease Models, Animal; Egtazic Acid; Erythrocyte Membrane; Erythrocytes; Exocytosis; Female; Malaria, Falciparum; Merozoites; Mice; Mice, Inbred BALB C; Microscopy, Video; Plasmodium falciparum; Protozoan Proteins; Subtilisins | 2013 |
Involvement of the ubiquitin-proteasome system in the early stages of wallerian degeneration.
Topics: Amino Acids; Animals; Animals, Newborn; Axons; Benzimidazoles; Blotting, Western; Calpain; Cells, Cultured; Chelating Agents; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Cytoskeleton; Disease Models, Animal; Drug Interactions; Egtazic Acid; Endopeptidases; Ganglia, Sympathetic; Immunohistochemistry; Leupeptins; Microtubules; Multienzyme Complexes; Nerve Growth Factor; Optic Nerve; Optic Nerve Injuries; Peptide Fragments; Proteasome Endopeptidase Complex; Rats; Time Factors; Tubulin; Ubiquitin; Wallerian Degeneration | 2003 |
Hyperosmolar solutions selectively block action potentials in rat myelinated sensory fibers: implications for diabetic neuropathy.
Topics: Action Potentials; Animals; Calcium; Chelating Agents; Diabetic Neuropathies; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Egtazic Acid; Electric Stimulation; Electrophysiology; Ganglia, Spinal; Glucose; In Vitro Techniques; Male; Mannitol; Membrane Potentials; Nerve Fibers, Myelinated; Neural Conduction; Osmolar Concentration; Rats; Rats, Sprague-Dawley; Sodium Chloride; Sucrose; Time Factors | 2004 |
A novel benzodiazepine increases the sensitivity of B cells to receptor stimulation with synergistic effects on calcium signaling and apoptosis.
Topics: Animals; Apoptosis; B-Lymphocytes; Benzodiazepines; Calcium; Calcium Signaling; Cells, Cultured; Chelating Agents; Disease Models, Animal; Egtazic Acid; Female; Fluorescent Dyes; Germinal Center; Humans; Lupus Erythematosus, Systemic; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Molecular Structure; Receptors, Antigen, B-Cell; Superoxides | 2004 |
Cell-permeant calcium buffer induced neuroprotection after cortical devascularization.
Topics: Animals; Brain Infarction; Brain Injuries; Brain Mapping; Cell Count; Cerebral Cortex; Chelating Agents; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Ectodysplasins; Egtazic Acid; Glial Fibrillary Acidic Protein; Histological Techniques; Immunohistochemistry; Male; Membrane Proteins; Phagocytes; Rats; Rats, Wistar; Time Factors | 2005 |
Blood pressure fall and increased relaxation of aortic smooth muscle in diabetic rats.
Topics: Animals; Aorta; Blood Glucose; Blood Pressure; Body Weight; Calcium; Calcium Signaling; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Diabetes Mellitus, Experimental; Disease Models, Animal; Egtazic Acid; Endothelium, Vascular; Female; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Vasodilation | 2005 |
Late N-methyl-D-aspartate receptor blockade rescues hippocampal neurons from excitotoxic stress and death after 4-aminopyridine-induced epilepsy.
Topics: 4-Aminopyridine; Animals; Cell Count; Cell Death; Chelating Agents; Disease Models, Animal; Dizocilpine Maleate; Drug Interactions; Egtazic Acid; Electroencephalography; Epilepsy; Excitatory Amino Acid Antagonists; Functional Laterality; Glutamic Acid; Hippocampus; Male; Microdialysis; Nerve Degeneration; Neurons; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Stress, Physiological; Time Factors | 2005 |
Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts.
Topics: Animals; Apoptosis; Bile Ducts; Calcium; Cell Proliferation; Cholestasis; Cytoprotection; Disease Models, Animal; Egtazic Acid; Enzyme Activation; Epithelium; Ligation; Male; Mitogen-Activated Protein Kinase Kinases; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinase C-alpha; Rats; Rats, Inbred F344; Signal Transduction; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid; Vagotomy | 2006 |
Diminished degradation of myelin basic protein by anti-sulfatide antibody and interferon-gamma in myelin from glia maturation factor-deficient mice.
Topics: Animals; Antibodies; Calcium; Chelating Agents; Disease Models, Animal; Drug Interactions; Egtazic Acid; Gene Expression; Glia Maturation Factor; Interferon-gamma; Male; Mice; Mice, Knockout; Myelin Basic Protein; Myelin Proteins; Myelin Sheath; Myelin-Associated Glycoprotein; Myelin-Oligodendrocyte Glycoprotein; Neuritis, Autoimmune, Experimental; Sulfoglycosphingolipids | 2007 |
The lipophilic metal chelators DP-109 and DP-460 are neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Biomarkers; Cell Survival; Central Nervous System; Chelating Agents; Disease Models, Animal; Egtazic Acid; Female; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Membrane Lipids; Metals; Mice; Mice, Transgenic; Nerve Degeneration; Neuroprotective Agents; Oxidative Stress; RNA, Messenger; Superoxide Dismutase; Superoxide Dismutase-1; Treatment Outcome; Vascular Endothelial Growth Factor A | 2007 |
Enhanced astrocytic Ca2+ signals contribute to neuronal excitotoxicity after status epilepticus.
Topics: Animals; Anticonvulsants; Astrocytes; Calcium; Calcium Signaling; Cell Death; Chelating Agents; Disease Models, Animal; Egtazic Acid; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; In Vitro Techniques; Male; Membrane Potentials; Mice; Neurons; Patch-Clamp Techniques; Pilocarpine; Piperidines; Receptors, Glutamate; Status Epilepticus; Time Factors | 2007 |
Disrupted intracellular calcium regulates BACE1 gene expression via nuclear factor of activated T cells 1 (NFAT 1) signaling.
Topics: Active Transport, Cell Nucleus; Aging; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Calcineurin; Calcineurin Inhibitors; Calcium; Calcium Signaling; Cells, Cultured; Chelating Agents; Cyclosporine; Disease Models, Animal; DNA-Binding Proteins; Egtazic Acid; Enzyme Activation; Humans; Ionophores; Mice; Neuroblastoma; NFATC Transcription Factors; Promoter Regions, Genetic; Up-Regulation | 2008 |
Metabolic alkalosis in models of primary and secondary hyperparathyroid states.
Topics: Acid-Base Equilibrium; Alkalosis; Animals; Disease Models, Animal; Dogs; Egtazic Acid; Electrolytes; Hydrogen-Ion Concentration; Hyperparathyroidism; Parathyroid Glands; Parathyroid Hormone; Thyroidectomy; Urine | 1983 |
Hyperalgesic effects of divalent cations and antinociceptive effects of a calcium chelator in naive and morphine-dependent mice.
Topics: Animals; Calcium; Cations; Disease Models, Animal; Egtazic Acid; Ethylene Glycols; Humans; Hyperalgesia; Male; Mice; Morphine Dependence; Nociceptors; Substance Withdrawal Syndrome | 1980 |
Increased intracellular Ca2+: a critical link in the pathophysiology of sepsis?
Topics: Animals; Aorta, Thoracic; Calcium; Chelating Agents; Dantrolene; Disease Models, Animal; Egtazic Acid; Fluorine; In Vitro Techniques; Kinetics; Magnetic Resonance Spectroscopy; Male; Muscle, Smooth, Vascular; Peritonitis; Rats; Rats, Sprague-Dawley; Reference Values; Second Messenger Systems; Sepsis | 1993 |
Oxyhemoglobin-induced cytotoxicity and arachidonic acid release in cultured bovine endothelial cells.
Topics: Animals; Arachidonic Acid; Cattle; Cell Size; Cells, Cultured; Cytotoxins; Disease Models, Animal; Dose-Response Relationship, Drug; Egtazic Acid; Endothelium, Vascular; Ischemic Attack, Transient; Oxyhemoglobins; Phospholipases A; Phospholipases A2; Superoxide Dismutase; Tritium; von Willebrand Factor | 1993 |
Effects of zinc and divalent cation chelators on ATP hydrolysis and Ca deposition by rachitic rat matrix vesicles.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Bone Matrix; Calcium; Chelating Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Egtazic Acid; Growth Plate; Hydrolysis; Microscopy, Electron; Phenanthrolines; Rats; Rickets; Zinc | 1995 |
Effects of hypertrophy on regional action potential characteristics in the rat left ventricle: a cellular basis for T-wave inversion?
Topics: 4-Aminopyridine; Action Potentials; Animals; Cell Membrane; Chelating Agents; Disease Models, Animal; Egtazic Acid; Electric Conductivity; Electrocardiography; Endocardium; Heart Conduction System; Hypertrophy, Left Ventricular; In Vitro Techniques; Isotonic Solutions; Male; Muscle Fibers, Skeletal; Organ Size; Rats; Rats, Wistar | 1997 |
Altered mitochondrial oxidative phosphorylation in hippocampal slices of kainate-treated rats.
Topics: Animals; Benzimidazoles; Calcium; Chelating Agents; Coloring Agents; Disease Models, Animal; Egtazic Acid; Epilepsy; Excitatory Amino Acid Agonists; Hippocampus; Kainic Acid; Male; Mitochondria; NADP; Neurons; Organ Culture Techniques; Oxidative Phosphorylation; Oxygen Consumption; Potassium Chloride; Rats; Rats, Sprague-Dawley; Ruthenium Red; Sodium-Potassium-Exchanging ATPase; Uncoupling Agents | 1999 |
Parathyroid hormone is not a key hormone in the rapid minute-to-minute regulation of plasma Ca2+ homeostasis in rats.
Topics: Animals; Calcium; Chelating Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Egtazic Acid; Homeostasis; Hypocalcemia; Male; Parathyroid Hormone; Parathyroidectomy; Peptide Fragments; Rats; Rats, Inbred Strains; Time Factors | 1999 |
Initiation of network bursts by Ca2+-dependent intrinsic bursting in the rat pilocarpine model of temporal lobe epilepsy.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Chelating Agents; Disease Models, Animal; Egtazic Acid; Electric Stimulation; Electrophysiology; Epilepsy, Temporal Lobe; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Hippocampus; Humans; In Vitro Techniques; Male; Nickel; Pilocarpine; Pyramidal Cells; Rats | 2001 |
Metabolic disorder in myocardiac intracellular free calcium after thermal injury.
Topics: Adenosine Triphosphate; Animals; Burns; Calcium; Calcium Metabolism Disorders; Cardiomyopathies; Chelating Agents; Disease Models, Animal; Egtazic Acid; Magnetic Resonance Spectroscopy; Male; Myocardium; Perfusion; Probability; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2001 |
Disturbance of membrane function preceding ischemic delayed neuronal death in the gerbil hippocampus.
Topics: Animals; Calcium; Cell Death; Disease Models, Animal; Egtazic Acid; Gerbillinae; Guanosine 5'-O-(3-Thiotriphosphate); Hippocampus; Inositol 1,4,5-Trisphosphate; Ischemic Attack, Transient; Male; Membrane Potentials; Pyramidal Tracts; Reperfusion | 1992 |
Selective damage in striatum and hippocampus with in vitro anoxia.
Topics: Acetylcholine; Aerobiosis; Anaerobiosis; Animals; Calcium; Carbon Dioxide; Corpus Striatum; Disease Models, Animal; Dopamine; Egtazic Acid; Glutamates; Glutamic Acid; Hippocampus; Hypoxia; In Vitro Techniques; Male; Mice; Organ Specificity; Oxygen Consumption; Synaptosomes | 1988 |
Degradative enzyme systems in osteoarthritic cartilage.
Topics: Acid Phosphatase; Animals; Cartilage, Articular; Cytidine; Disease Models, Animal; Edetic Acid; Egtazic Acid; Endopeptidases; Glycosaminoglycans; Humans; Hydrogen-Ion Concentration; Metalloendopeptidases; Microbial Collagenase; Osteoarthritis; Rabbits; Thymidine | 1985 |